跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA RATIOPHARM 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA RATIOPHARM 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA RATIOPHARM 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Teva Pharma S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 19, 2020
Approval ID
03a643d235e16bd0
Company
Teva Pharma S.L.U.
Type
Standard
Approval Details
Approval Id
03a643d235e16bd0
Drug Cima Aemps Name
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA RATIOPHARM 10 MG/320 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85354
Holder Company Name
Teva Pharma S.L.U.
Marketing Company Name
Teva Pharma S.L.U.
Authorization Date
2020-08-19
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
10 mg/320 mg/25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Teva Pharma S.L.U.
Active Ingredients
AMLODIPINO BESILATO
13,88 mg
VALSARTAN
320 mg
HIDROCLOROTIAZIDA
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 19, 2020
Approval ID
03a643d235e16bd0
Type
Standard
Back to CIMA-AEMPS Approvals